Kajubi,1 in his letter to the editor, which was published in the February 14, 2000, issue of the ARCHIVES, makes a good case for the use of aspirin in type 2 diabetes mellitus, "in the absence of contraindications." Many patients with chronic diabetes have diabetic retinopathy and neovascularization and are prone to fundal bleeding. When should aspirin be contraindicated in a patient with diabetic retinopathy?
Ong HT. Aspirin in Diabetes: Beware of Retinopathy. Arch Intern Med. 2000;160(19):3004. doi:
* * SCHEDULED MAINTENANCE * *
The JAMA Network Sites will be conducting routine maintenance from 10/20/2017 through 10/21/2017. During this window access to content and authentication may be intermittently available. The JAMA Store will be completely unavailable during the maintenance window.